Why Targeted Drug Doesn't Benefit Patients With Early-Stage Lung Cancer

… survival in patients with early-stage lung cancer," says co-corresponding author David … lines of non-small-cell lung cancer, the most common form of lung cancer, to learn … findings include: In two non-small-cell lung cancer cell lines, erlotinib treatment killed …